Search

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, August 31, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Vinod Balachandran Awarded the 2023 FNIH Trailblazer Prize for Clinician-Scientists Vinod Balachandran, MD , hepatopancreatobiliary surgeon, was awarded the  2023 Trailblazer

The broad-spectrum antibiotic piperacillin-tazobactam used as perioperative prophylaxis significantly reduced surgical site infection (SSI) in patients undergoing open pancreatoduodenectomy (PD, or the Whipple procedure) compared with the standard-of-care cefoxitin, according to results from the first-ever registry-linked surgical clinical trial conducted in North America. The findings, published in JAMA on April 20, support using piperacillin-tazobactam as a standard of care for this patient population.

… Thursday, April 20, 2023 The broad-spectrum antibiotic piperacillin-tazobactam used as perioperative prophylaxis significantly reduced surgical site infection (SSI) in patients undergoing open pancreatoduodenectomy (PD, or the Whipple procedure) compared with the standard-of-care cefoxitin, according

Dr. Brown, whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation and cancer, was among 30 early career scientists nationwide selected for the 2025 class of scholars.

… Wednesday, October 1, 2025 Immunologist Chrysothemis Brown, MD, PhD , whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation, and cancer, was among 30 early-career scientists nationwide selected for the 2025

Learn about some of the most important advances in cancer treatment at MSK in 2025.

… Monday, December 15, 2025 Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in a variety of cancer treatments in 2025 — including new approaches to immunotherapy, targeted therapy, and surgical imaging. Highlights this year also included a stem cell–based therapy for Parkinson

New research from Sloan Kettering Institute investigators pinpoints altered cell metabolism as a cause of B cell lymphoma.

… Monday, June 22, 2020 Summary Scientists at the Sloan Kettering Institute have found that increased activity of a normal metabolic enzyme can lead to cancer. The enzyme, SHMT2, is a driver of a large portion of B cell lymphomas and could be a potential drug target. Because of how aggressively they divide

Research from investigators at the Sloan Kettering Institute shows how a brain circuit controls mating behavior in fruit flies.

… Thursday, June 25, 2020 Summary Sloan Kettering Institute scientists have discovered how a genetic switch in the brain controls mating behavior in female fruit flies. The insights contribute to scientists’ understanding of fundamental neurobiological processes, including those that may go awry in disease

Get tips from a Memorial Sloan Kettering dietitian if you’ve completely lost your appetite during cancer treatment.

… Thursday, October 17, 2019 Summary A Memorial Sloan Kettering expert offers strategies to help people with cancer who feel like they can’t eat anything. In the Kitchen CancerSmart: In the Kitchen with MSK Learn more Getting proper nutrition during cancer treatment is vital. As the body tries to cope

… Thursday, April 6, 2023 Memorial Sloan Kettering Cancer Center (MSK) researchers have discovered that innate immune signaling drives late cardiac toxicity after DNA-damaging cancer therapies. Their results, published in the Journal of Experimental Medicine on March 6, 2023, identify a targetable mechanism

Vice President Joseph Biden visited Memorial Sloan Kettering Cancer Center (MSK) for a roundtable discussion with MSK experts and members of the cancer community. The candid conversation, inspired by the “moonshot” initiative announced by President Obama, was led by Craig Thompson, MD, President and CEO of MSK. MSK’s Carol Brown, MD, Ross Levine, MD, and Robert Sidlow, MD, were also active participants in the discussion. For more information about the event or to request an interview with a MSK roundtable participant, please e-mail [email protected].

… Thursday, May 26, 2016 Vice President Joseph Biden visited Memorial Sloan Kettering Cancer Center (MSK) for a roundtable discussion with MSK experts and members of the cancer community. The candid conversation, inspired by the “moonshot” initiative announced by President Obama, was led by Craig Thompson

Earlier this year, MSK announced the formation of MSK Ventures, a dedicated venture capital fund which will enable MSK to systematically invest in and help develop, scale, and, in some instances, translate new discoveries and services while diversifying long-term revenue streams. Whitney Snider, MD, joined MSK as Inaugural Managing Partner, after most recently serving as Principle and Vice President of Life Sciences at Alexandria Venture Investments.

… Thursday, March 19, 2026 Earlier this year, MSK announced the formation of MSK Ventures , a dedicated venture capital fund which will enable MSK to systematically invest in and help develop, scale, and, in some instances, translate new discoveries and services while diversifying long-term revenue streams